Primecap Management Co. CA Has $329.88 Million Stake in CME Group Inc (NASDAQ:CME)

Primecap Management Co. CA lessened its position in CME Group Inc (NASDAQ:CME) by 0.3% in the first quarter, HoldingsChannel.com reports. The fund owned 2,004,343 shares of the financial services provider’s stock after selling 6,600 shares during the period. Primecap Management Co. CA’s holdings in CME Group were worth $329,875,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the stock. Oregon Public Employees Retirement Fund raised its stake in CME Group by 18,502.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 16,220,459 shares of the financial services provider’s stock worth $86,000 after purchasing an additional 16,133,266 shares in the last quarter. FMR LLC increased its position in CME Group by 114.7% during the 4th quarter. FMR LLC now owns 6,198,088 shares of the financial services provider’s stock worth $1,165,984,000 after purchasing an additional 3,310,989 shares in the last quarter. Norges Bank acquired a new position in CME Group during the 4th quarter worth approximately $597,417,000. BlackRock Inc. increased its position in CME Group by 8.2% during the 4th quarter. BlackRock Inc. now owns 24,250,752 shares of the financial services provider’s stock worth $4,562,052,000 after purchasing an additional 1,828,640 shares in the last quarter. Finally, Bessemer Group Inc. increased its position in CME Group by 19,784.0% during the 4th quarter. Bessemer Group Inc. now owns 1,278,539 shares of the financial services provider’s stock worth $240,518,000 after purchasing an additional 1,272,109 shares in the last quarter. 84.76% of the stock is owned by institutional investors and hedge funds.

NASDAQ CME traded down $0.19 on Friday, hitting $196.55. 7,197 shares of the company were exchanged, compared to its average volume of 1,352,356. The firm has a market cap of $71.00 billion, a PE ratio of 28.80, a P/E/G ratio of 4.57 and a beta of 0.24. CME Group Inc has a 12 month low of $158.35 and a 12 month high of $204.56. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.16.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.60 by $0.02. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. CME Group’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.86 earnings per share. On average, equities analysts predict that CME Group Inc will post 6.59 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.53%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio is presently 43.99%.

In other CME Group news, Director Charles P. Carey sold 10,000 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $179.02, for a total transaction of $1,790,200.00. Following the transaction, the director now owns 37,799 shares in the company, valued at $6,766,776.98. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the transaction, the chief financial officer now owns 35,354 shares in the company, valued at approximately $5,949,017.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,873 shares of company stock worth $9,385,174. 1.20% of the stock is owned by insiders.

CME has been the subject of a number of research analyst reports. Citigroup set a $205.00 price objective on shares of CME Group and gave the stock a “buy” rating in a research report on Friday, February 15th. Deutsche Bank lowered their price objective on shares of CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a research report on Friday, March 15th. ValuEngine upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 8th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Tuesday, May 14th. Finally, Bank of America set a $180.00 target price on shares of CME Group and gave the stock a “hold” rating in a report on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $188.87.

TRADEMARK VIOLATION WARNING: “Primecap Management Co. CA Has $329.88 Million Stake in CME Group Inc (NASDAQ:CME)” was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://sportsperspectives.com/2019/06/14/primecap-management-co-ca-has-329-88-million-stake-in-cme-group-inc-nasdaqcme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Should you buy a closed-end mutual fund?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.